Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants

被引：4

作者：

Chen, Zhaochun ^{[1
]}

Zhang, Peng ^{[2
]}

Matsuoka, Yumiko ^{[3
]}

Tsybovsky, Yaroslav ^{[4
]}

West, Kamille ^{[5
]}

Santos, Celia ^{[3
]}

Boyd, Lisa F. ^{[6
]}

Nguyen, Hanh ^{[1
]}

Pomerenke, Anna ^{[1
]}

Stephens, Tyler ^{[4
]}

Olia, Adam S. ^{[7
]}

Zhang, Baoshan ^{[7
]}

De Giorgi, Valeria ^{[5
]}

Holbrook, Michael R. ^{[8
]}

Gross, Robin ^{[8
]}

Postnikova, Elena ^{[8
]}

Garza, Nicole L. ^{[9
]}

Johnson, Reed F. ^{[9
]}

Margulies, David H. ^{[6
]}

Kwong, Peter D. ^{[7
]}

Alter, Harvey J. ^{[5
]}

Buchholz, Ursula J. ^{[3
]}

Lusso, Paolo ^{[2
]}

Farci, Patrizia ^{[1
]}

机构：

[1] NIAID, Hepat Pathogenesis Sect, Lab Infect Dis, NIH, Bethesda, MD 20892 USA

[2] NIAID, Lab Immunoregulat, NIH, Bethesda, MD USA

[3] NIAID, RNA Viruses Sect, Lab Infect Dis, NIH, Bethesda, MD USA

[4] Leidos Biomed Res Inc, Canc Res Technol Program, Frederick Natl Lab Canc Res, Frederick, MD USA

[5] NIH, Dept Transfus Med, Clin Ctr, Bethesda, MD USA

[6] NIAID, Mol Biol Sect, Lab Immune Syst Biol, NIH, Bethesda, MD USA

[7] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD USA

[8] NIAID, Integrated Res Facil, NIH, Frederick, MD USA

[9] NIAID, SARS CoV 2 Virol Core, Lab Viral Dis, NIH, Bethesda, MD USA

来源：

CELL REPORTS | 2022年 / 41卷 / 05期

基金：

美国国家卫生研究院;

关键词：

RECEPTOR-BINDING DOMAIN; CRYO-EM STRUCTURE; VALIDATION; SPIKE; REPLICATION; INFECTION; LIBRARIES; TOOLS; MODEL;

D O I：

10.1016/j.celrep.2022.111528

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

The emergence and global spread of the SARS-CoV-2 Omicron variants, which carry an unprecedented num-ber of mutations, raise serious concerns due to the reduced efficacy of current vaccines and resistance to therapeutic antibodies. Here, we report the generation and characterization of two potent human monoclonal antibodies, NA8 and NE12, against the receptor-binding domain of the SARS-CoV-2 spike protein. NA8 inter-acts with a highly conserved region and has a breadth of neutralization with picomolar potency against the Beta variant and the Omicron BA.1 and BA.2 sublineages and nanomolar potency against BA.2.12.1 and BA.4. Combination of NA8 and NE12 retains potent neutralizing activity against the major SARS-CoV-2 var-iants of concern. Cryo-EM analysis provides the structural basis for the broad and complementary neutral-izing activity of these two antibodies. We confirm the in vivo protective and therapeutic efficacies of NA8 and NE12 in the hamster model. These results show that broad and potent human antibodies can overcome the continuous immune escape of evolving SARS-CoV-2 variants.

引用

页数：25

共 50 条

[21] Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern
Favorskaya, Irina A.
Shcheblyakov, Dmitry V.
Esmagambetov, Ilias B.
Dolzhikova, Inna V.
Alekseeva, Irina A.
Korobkova, Anastasia I.
Voronina, Daria V.
Ryabova, Ekaterina I.
Derkaev, Artem A.
Kovyrshina, Anna V.
Iliukhina, Anna A.
Botikov, Andrey G.
Voronina, Olga L.
Egorova, Daria A.
Zubkova, Olga V.
Ryzhova, Natalia N.
Aksenova, Ekaterina I.
Kunda, Marina S.
Logunov, Denis Y.
Naroditsky, Boris S.
Gintsburg, Alexandr L.
FRONTIERS IN IMMUNOLOGY, 2022, 13
[22] Human antibodies can neutralize SARS-CoV-2
Catalan-Dibene J.
Nature Reviews Immunology, 2020, 20 (6) : 350 - 350
[23] In-Silico Analysis of Monoclonal Antibodies against SARS-CoV-2 Omicron
Hu, Ye-Fan
Hu, Jing-Chu
Chu, Hin
Yau, Thomas
Zhang, Bao-Zhong
Huang, Jian-Dong
VIRUSES-BASEL, 2022, 14 (02):
[24] Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern
Kovacech, Branislav
Fialova, Lubica
Filipcik, Peter
Skrabana, Rostislav
Zilkova, Monika
Paulenka-Ivanovova, Natalia
Kovac, Andrej
Palova, Denisa
Rolkova, Gabriela Paulikova
Tomkova, Katarina
Csokova, Natalia Turic
Markova, Karina
Skrabanova, Michaela
Sinska, Kristina
Basheer, Neha
Majerova, Petra
Hanes, Jozef
Parrak, Vojtech
Prcina, Michal
Cehlar, Ondrej
Cente, Martin
Piestansky, Juraj
Fresser, Michal
Novak, Michal
Slavikova, Monika
Borsova, Kristina
Cabanova, Viktoria
Brejova, Bronislava
Vinar, Tomas
Nosek, Jozef
Klempa, Boris
Eyer, Ludek
Honig, Vaclav
Palus, Martin
Ruzek, Daniel
Vyhlidalova, Tereza
Strakova, Petra
Mrazkova, Blanka
Zudova, Dagmar
Koubkova, Gizela
Novosadova, Vendula
Prochazka, Jan
Sedlacek, Radislav
Zilka, Norbert
Kontsekova, Eva
EBIOMEDICINE, 2022, 76
[25] Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies
Yamasoba, Daichi
Kosugi, Yusuke
Kimura, Izumi
Fujita, Shigeru
Uriu, Keiya
Ito, Jumpei
Sato, Kei
LANCET INFECTIOUS DISEASES, 2022, 22 (07): : 942 - 943
[26] Comparative Binding Ability of Human Monoclonal Antibodies against Omicron Variants of SARS-CoV-2: An In Silico Investigation
Das, Nabarun Chandra
Chakraborty, Pritha
Bayry, Jagadeesh
Mukherjee, Suprabhat
ANTIBODIES, 2023, 12 (01)
[27] Susceptibility of SARS-CoV-2 Omicron Variants to Therapeutic Monoclonal Antibodies: Systematic Review and Meta-analysis
Tao, Kaiming
Tzou, Philip L.
Pond, Sergei L. Kosakovsky
Ioannidis, John P. A.
Shafer, Robert W.
MICROBIOLOGY SPECTRUM, 2022, 10 (04):
[28] Protection from successive Omicron variants with SARS-CoV-2 vaccine and monoclonal antibodies in kidney transplant recipients
Moal, Valerie
Valade, Margaux
Boschi, Celine
Robert, Thomas
Orain, Nicolas
Bancod, Audrey
Edouard, Sophie
Colson, Philippe
La Scola, Bernard
FRONTIERS IN MICROBIOLOGY, 2023, 14
[29] Potent mouse monoclonal antibodies that block SARS-CoV-2 infection
Guo, Youjia
Kawaguchi, Atsushi
Takeshita, Masaru
Sekiya, Takeshi
Hirohama, Mikako
Yamashita, Akio
Siomi, Haruhiko
Murano, Kensaku
JOURNAL OF BIOLOGICAL CHEMISTRY, 2021, 296
[30] Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2
Fiaschi, Lia
Dragoni, Filippo
Schiaroli, Elisabetta
Bergna, Annalisa
Rossetti, Barbara
Giammarino, Federica
Biba, Camilla
Gidari, Anna
Lai, Alessia
Nencioni, Cesira
Francisci, Daniela
Zazzi, Maurizio
Vicenti, Ilaria
VIRUSES-BASEL, 2022, 14 (07):

← 1 2 3 4 5 →